Endesa, S.A. (ELEZF)

Verve Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	226	840	2,106	871	703	403
Accounts Receivable	3,781	3,530	4,125	4,455	4,340	2,193
Other Receivables	819	1,606	1,807	3,488	1,795	1,763
Inventory	1,512	1,831	2,060	2,122	1,343	1,077
Loans Receivable Current	-	226	82	90	183	291
Other Current Assets	1,369	1,080	2,278	8,899	3,288	507
Total Current Assets	7,707	9,113	12,458	19,925	11,652	6,234
Property, Plant & Equipment	23,832	22,940	22,839	22,338	22,097	21,354
Goodwill	587	462	462	462	462	462
Other Intangible Assets	1,513	1,536	1,646	1,636	1,542	1,399
Long-Term Investments	285	334	336	390	193	230
Long-Term Loans Receivable	-	144	83	50	94	86
Long-Term Deferred Tax Assets	1,273	1,311	1,608	2,660	2,362	1,391
Other Long-Term Assets	1,810	1,505	1,851	2,606	1,566	906
Total Assets	37,007	37,345	41,283	50,067	39,968	32,062
Accounts Payable	4,621	4,057	5,028	4,794	3,811	3,739
Accrued Expenses	592	704	550	615	486	492
Current Portion of Long-Term Debt	661	527	4,023	6,696	3,086	1,309
Current Unearned Revenue	509	487	427	294	270	274
Current Portion of Leases	-	86	84	88	82	63
Current Income Taxes Payable	961	309	215	544	333	512
Other Current Liabilities	1,265	2,800	4,248	7,651	7,754	2,166
Total Current Liabilities	8,609	8,970	14,575	20,682	15,822	8,555
Long-Term Debt	9,773	9,219	8,897	11,035	6,363	5,197
Long-Term Leases	-	698	784	756	861	740
Long-Term Unearned Revenue	4,659	4,662	4,575	4,538	4,538	4,517
Pension & Post-Retirement Benefits	233	227	268	278	659	757
Long-Term Deferred Tax Liabilities	1,168	1,047	1,308	1,425	1,486	1,053
Other Long-Term Liabilities	3,387	3,469	3,672	5,595	4,695	3,778
Total Liabilities	27,829	28,292	34,079	44,309	34,424	24,597
Common Stock	1,271	1,271	1,271	1,271	1,271	1,271
Additional Paid-In Capital	6,087	89	89	89	89	89
Retained Earnings	1,041	6,510	5,601	7,066	5,523	6,008
Treasury Stock	-214	-4	-4	-5	-3	-2
Comprehensive Income & Other	91	244	60	-2,864	-1,500	-51
Total Common Equity	8,276	8,110	7,017	5,557	5,380	7,315
Minority Interest	902	943	187	201	164	150
Shareholders' Equity	9,178	9,053	7,204	5,758	5,544	7,465
Total Liabilities & Equity	37,007	37,345	41,283	50,067	39,968	32,062
Total Debt	10,434	10,530	13,788	18,575	10,392	7,309
Net Cash (Debt)	-10,208	-9,690	-11,682	-17,704	-9,689	-6,906
Net Cash Per Share	-9.68	-9.15	-11.04	-16.72	-9.15	-6.52
Filing Date Shares Outstanding	1,044	1,059	1,059	1,058	1,059	1,059
Total Common Shares Outstanding	1,044	1,059	1,059	1,058	1,059	1,059
Working Capital	-902	143	-2,117	-757	-4,170	-2,321
Book Value Per Share	7.93	7.66	6.63	5.25	5.08	6.91
Tangible Book Value	6,176	6,112	4,909	3,459	3,376	5,454
Tangible Book Value Per Share	5.91	5.77	4.64	3.27	3.19	5.15
Land	-	417	426	314	332	252
Buildings	-	1,798	1,563	1,368	1,141	881
Machinery	-	28,578	28,058	27,593	27,013	26,511
Construction In Progress	-	1,261	1,526	1,241	1,283	1,152

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.